Key Facts

Latest information about our company.

Global Business

Updated November 2021

Chief Executive Officer:
Headquarters:
New York City
Business:
Biopharmaceuticals
Web Address:
NYSE Listing:
BMY
Full-year Revenue (2020):
$42.5B
R&D Investment (2020):
$11.1 billion which included the discovery and development of new medicines for patients
Principal Locations:
COVID-19: Our Response and Path Forward
Coronavirus

Contact:

1 800 267-1088

Local Business

Updated November 2021

General Manager:
Troy Andre
Head Office:
Montreal, Quebec, Canada
Address:
2344 Alfred-Nobel,
Suite 300
Saint-Laurent, QC
H4S 0A4
CANADA
Areas of Focus:
Oncology
Hematology
Immunology
Cardiovascular disease
Key products :
ABECMATM (idecabtagene vicleucel)
ELIQUIS® (apixaban)
ONUREG ® (azacitidine tablets)
OPDIVO® (nivolumab)
ORENCIA® (abatacept)
POMALYST® (pomalidomide)
REBLOZYL® (luspatercept)
REVLIMID® (lenalidomide)
YERVOY® (ipilimumab)
ZEPOSIA® (ozanimod)